| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
- Reuters
Clearmind Medicine secures a U.S. patent for its MEAI-based binge behavior treatment, marking a significant advancement in addr...
Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "company"), a biotech company focused on...
SciSparc has been collaborating with Clearmind Medicine to create effective treatments for obesity and metabolic syndrome by co...
This partnership aims to source global manufacturers and distributors for Clearmind's groundbreaking MEAI-based alcohol sub...
